Results 191 to 200 of about 24,883,480 (353)

Obstructive sleep apnea as a risk factor for stroke and death.

New England Journal of Medicine, 2005
H. Yaggi, J. Concato, W. Kernan, J. Lichtman, L. Brass, V. Mohsenin   +5 more
semanticscholar   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Lipoprotein(a): the neglected risk factor in cardiovascular health. [PDF]

Front Cardiovasc Med
Irvine A, Watt J, Kurth MJ, Mooney L, Clark-McKellar J, Keteepe-Arachi T, Lamont JV, Dowey LR, Fitzgerald P, Ruddock MW.   +9 more
europepmc   +1 more source

A Prospective Analysis of the Contralateral Hip Among Patients With Femoroacetabular Impingement: What Are the Risk Factors for Disease Progression?

, 2018
Craig R. Louer, Gail Pashos, John C. Clohisy, Jeffrey J. Nepple   +3 more
openalex   +2 more sources

Environmental Risk Factors for Pediatric Acute Leukemia: Methodology and Early Findings

, 2023
Pardis Nematollahi, Sina Arabi, Marjan Mansourian, Saeed Yousefian, Alireza Moafi, SayedNassereddin Mostafavi, AmirmansourAlavi Naeini, Afshin Ebrahimi, Karim Ebrahimpour, Mohammad Mehdi Amin, Aryan Kavosh, Niayesh Radfar, Azar Naimi, Roya Kelishadi   +13 more
openalex   +1 more source

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

European Journal of Preventive Cardiology, 2016
K. Kotseva, D. Wood, D. De Bacquer, G. De Backer, L. Rydén, C. Jennings, V. Gyberg, P. Amouyel, J. Bruthans, A. Castro Conde, R. Cífková, J. Deckers, J. De Sutter, M. Dilić, M. Dolzhenko, A. Erglis, Z. Fras, D. Gaita, N. Gotcheva, J. Goudevenos, P. Heuschmann, A. Laucevičius, S. Lehto, D. Lovic, D. Miličić, D. Moore, E. Nicolaides, R. Oganov, A. Pająk, N. Pogosova, Ž. Reiner, M. Stagmo, S. Störk, L. Tokgözoğlu, D. Vulic   +34 more
semanticscholar   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

Commentary: Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia

Frontiers in Psychiatry, 2021
Tauseef A. Khan, Tauseef A. Khan, Tauseef A. Khan, John L. Sievenpiper, John L. Sievenpiper, John L. Sievenpiper, John L. Sievenpiper, John L. Sievenpiper, John D. Fernstrom, John D. Fernstrom   +9 more
doaj   +1 more source

Farmers’ assessment of plant biosecurity risk management strategies and influencing factors: A study of smallholder farmers in Australia [PDF]

, 2019
Thi Tam Duong, Tom Brewer, Jo Luck, Kerstin K. Zander   +3 more
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source